Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

12th European Diabetes Congress

Berlin, Germany

Joseph Shemesh

Joseph Shemesh

Tel Aviv University, Israel

Title: Diabetes is not a homogenous risk: The role of coronary calcium score in the reclassification of cardiovascular risk in diabetic patients

Biography

Biography: Joseph Shemesh

Abstract

Coronary artery calcification (CAC) is the best surrogate marker of the total burden of coronary atherosclerosis. Its presence in asymptomatic subjects indicates sub-clinical disease and its quantity reflects the extent and the chronicity of the disease. CAC can be easily measured and reported by radiologists while reading chest CT. The presence or absence of CAC contributes to the reclassification of diabetic patients, pre-diabetics and those with metabolic syndrome as well. Prospective studies demonstrated that approximately one third of asymptomatic, middle aged, diabetic patients have no CAC detected indicating an excellent prognosis. In a meta-analysis of 8 studies that includes 6521 diabetics with a follow-up of 5.8 years, the presence of CAC is associates with a relative risk of 5.47 for all cause mortality or CV events and 9.22 for fatal and non fatal CV events. The recently published MESA CHD risk score is the first available algorithm incorporating CAC with traditional risk factors for 10-year risk prediction. For example in a 60 years old diabetic Caucasian male without CAC, the estimated 10-year MESA score risk of CHD event including the CAC score=0 is reduced to 3.5% compared to 9.3% if one did not factor in his CAC score. In summary, CAC reflects the atherosclerosis sequelae of the individual long-life global exposure to all the risk and protecting factors. It contributes to reclassify risk in diabetic patients and may improve individualized treatment.

Speaker Presentations

Speaker PPTs Click Here